Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis through Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9-Mediated Low-density Lipoprotein Receptor Degradation
Zhu, Bo, Krishan Gupta, Kui Cui, Beibei Wang, Marina V. Malovitchko, Kathryn S. Li, Hao Wu, et al. 2024. “Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis through Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9-Mediated Low-Density Lipoprotein Receptor Degradation”. BioRxiv 2024.08.26.609742.